Comparison between Suraksha Diagnostic IPO and Vishal Mega Mart IPO.
Suraksha Diagnostic IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Vishal Mega Mart IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Suraksha Diagnostic IPO is up to ₹846.25 Cr whereas the issue size of the Vishal Mega Mart IPO is up to ₹8,000.00 Cr. The final issue price of Suraksha Diagnostic IPO is ₹441.00 per share and of Vishal Mega Mart IPO is ₹78.00 per share.
| Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹420.00 per share | ₹74.00 per share |
| Issue Price (Upper) | ₹441.00 per share | ₹78.00 per share |
| Issue Price (Final) | ₹441.00 per share | ₹78.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 34 shares | 190 shares |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,91,89,330 shares | 1,02,56,41,025 shares |
| OFS Issue Size (Amount) | up to ₹846.25 Cr | up to ₹8,000.00 Cr |
| Issue Size Total | 1,91,89,330 shares | 1,02,56,41,025 shares |
| Issue Size Total (Amount) | up to ₹846.25 Cr | up to ₹8,000.00 Cr |
Suraksha Diagnostic IPO opens on Nov 29, 2024, while Vishal Mega Mart IPO opens on Dec 11, 2024. The closing date of Suraksha Diagnostic IPO and Vishal Mega Mart IPO is Dec 03, 2024, and Dec 13, 2024, respectively.
| Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
|---|---|---|
| Anchor Bid Date | Nov 28, 2024 | Dec 10, 2024 |
| Issue Open | Nov 29, 2024 | Dec 11, 2024 |
| Issue Close | Dec 03, 2024 | Dec 13, 2024 |
| Basis Of Allotment (Tentative) | Dec 04, 2024 | Dec 16, 2024 |
| Initiation of Refunds (Tentative) | Dec 05, 2024 | Dec 17, 2024 |
| Credit of Share (Tentative) | Dec 05, 2024 | Dec 17, 2024 |
| Listing date (Tentative) | Dec 06, 2024 | Dec 18, 2024 |
| Anchor Lockin End date 1 | Jan 03, 2025 | Jan 14, 2025 |
| Anchor Lockin End date 2 | Mar 04, 2025 | Mar 15, 2025 |
Suraksha Diagnostic IPO P/E ratio is 99.31, as compared to Vishal Mega Mart IPO P/E ratio of 76.13.
| Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 61.07 | 98.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 48.78 | 76.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 99.31 | 76.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2296.76 Cr. | ₹35168.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.09% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.46% | 68.76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.44 | ₹1.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 14.09% | 8.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Suraksha Diagnostic IPO Retail Individual Investors (RII) are offered 67,16,266 shares while in Vishal Mega Mart IPO retail investors are offered 67,16,266 shares. Qualified Institutional Buyers (QIB) are offered 38,37,867 shares in Suraksha Diagnostic IPO and 20,51,28,205 shares in Vishal Mega Mart IPO.
| Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
|---|---|---|
| Anchor Investor Reservation | 57,56,797 shares | 30,76,92,307 shares |
| Market Maker Reservation | ||
| QIB | 38,37,867 shares | 20,51,28,205 shares |
| NII | 28,78,400 shares | 15,38,46,154 shares |
| RII | 67,16,266 shares | 35,89,74,359 shares |
| Employee | ||
| Others | ||
| Total | 1,91,89,330 shares | 1,02,56,41,025 shares |
Suraksha Diagnostic IPO subscribed 1.27x in total, whereas Vishal Mega Mart IPO subscribed 28.75x.
| Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
|---|---|---|
| QIB (times) | 1.74x | 85.11x |
| NII (times) | 1.40x | 15.01x |
| Big NII (times) | 1.53x | 17.34x |
| Small NII (times) | 1.16x | 10.37x |
| RII (times) | 0.94x | 2.43x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.27x | 28.75x |
